#Immunotherapy

From nature.com

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm - Nature Reviews Clinical Oncology

1 1

Over the past few years, several novel therapies, including targeted therapies for specific subgroups as well as several non-targeted therapies, have been developed and approved for patients with chemorefractory metastatic colorectal cancer (CRC). Nonetheless, selecting patients who are most...

#cancer #science #oncology #Immunotherapy #colorectalcancer

on Sat, 8PM